Information for patients, all in one place
On Friday July 2 2021, following consultation with the Therapeutic Goods Administration (TGA) and Medsafe, Philips Australia and New Zealand announced an Urgent Product Defect Correction in Australia and Recall for Product Correction in New Zealand for specific Philips Continuous Positive Airway Pressure (CPAP), BiLevel Positive Airway Pressure (BiLevel PAP) devices, and Mechanical Ventilators.
Our teams have been and continue to work on a comprehensive correction program to support patients with an affected device. As a first step, if your device is affected, please start the registration process here.
Patient safety is our top priority, and we are committed to supporting you and your care team throughout the correction process. Be sure to visit this page regularly for the most current and accurate information. Thank you for your patience and continued trust.
If you have questions about the correction process or need additional support once you have received your replacement device, please visit our Contact and Support page.
Our goods and services come with guarantees that cannot be excluded under the Australian and New Zealand Consumer Law. Your rights under the Australian and New Zealand Consumer Law are in addition to any remedy the local Philips entity may provide you.
Ozone and UV light cleaning products are not currently approved cleaning methods for sleep apnoea devices or masks and should not be used.
Please refer to the most recent User Manual for more detailed information about the device and operation, including cleaning and adjusting your patient settings. Images may vary.
Resources from Philips Respironics
Further information in relation to the global recall and devices has been made available by the legal manufacturer, Philips RS North America LLC (Philips Respironics), a company based in the USA.
The following updates in relation to device testing have been released by Philips Respironics on this webpage:
Please note that the Philips Respironics website also contains information specific to the CPAP, BiPAP and mechanical ventilator device recall in the USA, which may be different to and not relevant for Australia and New Zealand. This information has not been separately verified by Philips Electronics Australia Ltd.
Resources from Royal Philips
Further information in relation to the global recall has been made available by Koninklijke Philips N.V. (Royal Philips), a company based in the Netherlands.
The following updates in relation to the global recall and recent media articles have been released by Royal Philips on the below webpages:
This information has not been separately verified by Philips Electronics Australia Ltd.
Support at every step of the way
Questions and answers
DreamStation ASV
Also known as DreamStation BiPAP autoSV
DreamStation AVAPS
Also known as DreamStation BiPAP AVAPS, DreamStation BiPAP S/T
SystemOne ASV4 (50 and 60 Series)
Also known as System One BiPAP autoSV, System One BiPAP autoSV Advanced
C Series S/T, AVAPS (50 and 60 Series)
Also known as System One BiPAP AVAPS (C-Series), System One BiPAP S/T (C-Series)
OmniLab Advanced Plus
In-Lab Titration Device
Continuous Ventilator, Non-life Supporting
A-Series BiPAP A40
Also known as BiPAP A40 Ventilator (A-Series)
(not marketed in US)
A-Series BiPAP A30
Also known as BiPAP A30 Ventilator (A-Series)
(not marketed in US)
If your device is affected...
What products are not affected and why?
Products that are not affected may have different sound abatement foam materials, as new materials and technologies are available over time. Also, sound abatement foam in unaffected devices may be placed in a different location due to device design.
